Carol Stuckley
Director/Board Member presso CENTESSA PHARMACEUTICALS PLC
Patrimonio netto: - $ in data 31/03/2024
Profilo
Carol Stuckley currently works at Transgene SA, as Independent Director from 2023 and Centessa Pharmaceuticals Plc, as Independent Non-Executive Director from 2021.
Ms. Stuckley also formerly worked at Ipsen SA, as Independent Director from 2017 to 2021, Epizyme, Inc., as Independent Director from 2021 to 2022, Financial Executives International of Fort Worth Chapter, as President & Director, Pfizer Inc., as Vice President-Finance & Assistant Treasurer, Galderma Laboratories LP, as Chief Financial Officer & Senior VP-Finance from 2010 to 2013, and Healthcare Payment Specialists LLC, as Chief Financial Officer & Senior Vice President from 2015 to 2019.
Ms. Stuckley received her undergraduate degree in 1977 from the University of Delaware and graduate degree in 1980 and Masters Business Admin degree in 1979 from Fox School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 22/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Carol Stuckley
| Società | Posizione | Inizio |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Director/Board Member | 17/05/2021 |
| TRANSGENE | Director/Board Member | 05/05/2023 |
Precedenti posizioni note di Carol Stuckley
| Società | Posizione | Fine |
|---|---|---|
| EPIZYME, INC. | Director/Board Member | 12/08/2022 |
| IPSEN | Director/Board Member | 01/08/2021 |
Healthcare Payment Specialists LLC
 Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Healthcare Payment Specialists LLC provides payment and reimbursement solutions. The firm’s solutions include Stingary SAAS, Medicare bad debt, Medicare disproportionate share, Shadow billing compliance, Transfer DRG, Volume decrease adjustment and Complex drug review. It also offers consulting services. The company was founded in 2002 by Peter Jarvis and is headquartered in Fort Worth, TX. | Director of Finance/CFO | 01/07/2019 |
Galderma Laboratories LP
 Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | Director of Finance/CFO | 01/01/2013 |
| Financial Executives International of Fort Worth Chapter | President | - |
Formazione di Carol Stuckley
| University of Delaware | Undergraduate Degree |
| Fox School of Business | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| TRANSGENE | Health Technology |
| IPSEN | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Aziende private | 4 |
|---|---|
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Healthcare Payment Specialists LLC
Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Healthcare Payment Specialists LLC provides payment and reimbursement solutions. The firm’s solutions include Stingary SAAS, Medicare bad debt, Medicare disproportionate share, Shadow billing compliance, Transfer DRG, Volume decrease adjustment and Complex drug review. It also offers consulting services. The company was founded in 2002 by Peter Jarvis and is headquartered in Fort Worth, TX. | Commercial Services |
| Financial Executives International of Fort Worth Chapter |
- Borsa valori
- Insiders
- Carol Stuckley
